Literature DB >> 18269602

Mental health in patients with systemic sclerosis: a controlled investigation.

A Mozzetta1, V Antinone, S Alfani, P Neri, P G Foglio Bonda, P Pasquini, P Puddu, A Picardi.   

Abstract

BACKGROUND: Despite the undeniable impact of systemic sclerosis (SS) on quality of life, only a few studies so far have focused on its psychiatric or psychological aspects. We aimed at assessing psychiatric symptoms and self-image in inpatients with SS and comparing them with patients with either a very mild skin condition or a serious skin condition.
METHODS: Three groups were recruited: (i) 38 consecutive female inpatients with SS; (ii) 38 age-matched female outpatients with melanocytic naevi; (iii) 35 age-matched female inpatients with melanoma. All participants completed the Zung Anxiety Scale, the Zung Depression Scale and a self-report questionnaire measuring self-perceived personal qualities. Patients with SS were also clinically interviewed by a psychologist.
RESULTS: The clinical interview revealed the presence of a psychiatric disorder in most (81%) patients with SS. The Zung scales corroborated the presence of mild to moderate anxiety and depression among patients with SS, who scored significantly higher than patients with either naevi or melanoma on both scales. Scores on the questionnaire assessing self-perceived personal qualities were very similar in the three groups and indicated a fairly high level of self-esteem.
CONCLUSIONS: This study suggested that psychosocial issues are quite relevant in patients with SS and underscored the need for a biopsychosocial approach to the clinical management of these patients. Timely detection of psychosocial difficulties and appropriate psychological or psychiatric intervention may represent important steps toward better adherence to medical treatment and improved psychological well-being and quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18269602     DOI: 10.1111/j.1468-3083.2007.02426.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

2.  Illness Identity in Adults with a Chronic Illness.

Authors:  Leen Oris; Koen Luyckx; Jessica Rassart; Liesbet Goubert; Eva Goossens; Silke Apers; Seher Arat; Joris Vandenberghe; René Westhovens; Philip Moons
Journal:  J Clin Psychol Med Settings       Date:  2018-12

Review 3.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

4.  Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.

Authors:  Brittany L Adler; James W Russell; Laura K Hummers; Zsuzsanna H McMahan
Journal:  J Rheumatol       Date:  2018-06-15       Impact factor: 4.666

5.  Psychiatric symptoms and quality of life in systemic sclerosis.

Authors:  G Mura; Krishna M Bhat; A Pisano; G Licci; Mg Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-04-20

6.  Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.

Authors:  Agnes Bretterklieber; Clemens Painsi; Alexander Avian; Nora Wutte; Elisabeth Aberer
Journal:  BMC Res Notes       Date:  2014-09-02

7.  Trends in Demographics, Hospitalization Outcomes, Comorbidities, and Mortality Risk among Systemic Sclerosis Patients.

Authors:  Oluyemisi Amoda; Virendrasinh Ravat; Sorabh Datta; Bipin Saroha; Rikinkumar S Patel
Journal:  Cureus       Date:  2018-05-14

Review 8.  The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis.

Authors:  Nicola Farina; Giovanni Benanti; Giacomo De Luca; Anna Palmisano; Giovanni Peretto; Sara Tomassetti; Veronica Giorgione; Ornella Forma; Antonio Esposito; Silvio Danese; Lorenzo Dagna; Marco Matucci-Cerinic; Corrado Campochiaro
Journal:  J Multidiscip Healthc       Date:  2022-04-20

9.  Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.

Authors:  Christelle Nguyen; Brigitte Ranque; Thierry Baubet; Alice Bérezné; Caroline Mestre-Stanislas; François Rannou; Agathe Papelard; Sandrine Morell-Dubois; Michel Revel; Marie-Rose Moro; Loïc Guillevin; Serge Poiraudeau; Luc Mouthon
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study.

Authors:  Stephanie T Gumuchian; Sandra Peláez; Vanessa C Delisle; Marie-Eve Carrier; Lisa R Jewett; Ghassan El-Baalbaki; Catherine Fortune; Marie Hudson; Ann Impens; Annett Körner; Jennifer Persmann; Linda Kwakkenbos; Susan J Bartlett; Brett D Thombs
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.